HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels. - Wikidata - wikimedia - TriplyDB

HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels.

HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels.

http://www.wikidata.org/entity/Q35057427

about

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.

P2860

Q34781706-B0D8AA69-9DA2-47A9-BCC8-8BC5896F6A78 Q47546881-9AEE217A-32EB-4534-9834-B453CB84D53A

P2860

HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels.

http://www.wikidata.org/entity/Q35057427

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@ast

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@en

type

label

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@ast

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@en

prefLabel

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@ast

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@en

P1433

Q35057427-C9B6D7AF-7FFA-490D-8169-5D0F2B6D2BD0

P1476

Q35057427-B94DC7B4-B3C1-4E71-959F-046B3974990A

P2093

Q35057427-1E7D1094-A33A-402E-B7B7-F7F321667FC6

Q35057427-2AC6F7C3-3447-4482-B689-C2143D2A49B9

Q35057427-4C82A3C7-A13D-42AC-9539-DB770B583EDD

Q35057427-698073DF-37DA-43AF-912B-B669DF8589DF

Q35057427-80E04B90-9CD9-46B6-8C0D-3AE269A20060

Q35057427-856D96BC-1560-488D-80C1-85835CFA42DE

Q35057427-BE698E16-98FE-44FC-8055-ED3C52BF2002

Q35057427-D8CDF804-9EC4-4D7E-97AB-6E0A100B389B

Q35057427-D9EF5597-B4FF-423A-AECB-2745FBFDB9DF

P2860

Q35057427-05DABBF8-8C4A-4723-9A8B-044205B9F59D

Q35057427-0622BBAC-596E-4E0C-AA32-6222D04467F3

Q35057427-09C641EA-76BB-4703-A804-1F70B2585E07

Q35057427-2A0743C5-23D4-458F-B63A-02E0A854E6B5

Q35057427-2F31A045-4823-4A88-AC12-CE7B93999D40

Q35057427-33DDFCCA-3DF6-4EE8-B26A-2D725C0164F1

Q35057427-3CB27A7B-44F7-42F8-8C73-55844047D24A

Q35057427-4C2CF56F-7A79-49FE-B49A-CA11E56DC0C1

Q35057427-4EB28232-FF4E-41EA-B766-2BB16E45FD41

Q35057427-5DB5AD90-45DF-4ABE-A093-71DB4DDFAE47

P304

Q35057427-15C2577C-0B05-4EC5-B4AA-107AA0E83AE6

P31

Q35057427-D16FD248-B71B-47D6-A555-7981DD596356

P356

Q35057427-50DA7FC9-2D92-47BF-8603-F75FE1B8CF92

P433

Q35057427-6905689A-2C1A-4B30-AB2A-83C7B54B2B09

P478

Q35057427-3D16F48C-448F-4059-9A67-E8001D8A562C

P577

Q35057427-7D4352F9-812C-4224-806A-76348E556358

P698

Q35057427-046F6B8A-F4DC-41CF-BB04-98031947B28D

P932

Q35057427-37970603-B51B-4D29-9E94-8F7E66CA769C

P356

P1433

World journal of AIDS

P1476

HIV Drug Resistance Profiles a ...... Maintained at Very Low Levels.

@en

P2093

Aileen Tiro

http://www.w3.org/2001/XMLSchema#string

Christine Wanke

http://www.w3.org/2001/XMLSchema#string

Christopher Rowley

http://www.w3.org/2001/XMLSchema#string

Eoin P Coakley

http://www.w3.org/2001/XMLSchema#string

Julie Winsett

http://www.w3.org/2001/XMLSchema#string

Michael R Jordan

http://www.w3.org/2001/XMLSchema#string

Nobel Bellosillo

http://www.w3.org/2001/XMLSchema#string

Rony S Berbara

http://www.w3.org/2001/XMLSchema#string

Vuth Bau

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sequence alignment with the Clustal series of programs

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.

Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.

Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy

Cost-effectiveness of HIV testing and treatment in the United States

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

Web resources for HIV type 1 genotypic-resistance test interpretation.

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

P304

71-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4236/WJA.2013.32010

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25664219

http://www.w3.org/2001/XMLSchema#string

P932

4319662

http://www.w3.org/2001/XMLSchema#string